About MediSix Therapeutics
MediSix Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2019 in Delaware. It has reported $42,858,686 raised in two offerings on Form D since October 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2021 | Apr 13, 2021amended Aug 4, 2023 | $22,500,000fully sold | 5 | $4.5M | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 17, 2019 | Oct 2, 2019 | $20,358,686fully sold | 4 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $42,858,686 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MediSix Therapeutics's Form D filed Aug 4, 2023.
AB
Andrew Bruce
President and director
WH
William Harrington
Director
MC
Michael Carusi
Director
GP
George Poste
Director
Earlier filings also listed Sarah Lim (executive officer, last listed Oct 2019) and Kenneth Noonan (secretary and director, last listed Oct 2019).